These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 18363420

  • 1. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine.
    Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS.
    J Clin Psychiatry; 2008 Apr; 69(4):659-65. PubMed ID: 18363420
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
    Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.
    J Clin Psychiatry; 2006 Feb; 67(2):288-96. PubMed ID: 16566626
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of controlled-release paroxetine in the treatment of late-life depression.
    Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD.
    J Clin Psychiatry; 2003 Sep; 64(9):1065-74. PubMed ID: 14628982
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial.
    Yu YM, Gao KR, Yu H, Shen YF, Li HF.
    J Clin Psychopharmacol; 2018 Jun; 38(3):226-233. PubMed ID: 29620692
    [Abstract] [Full Text] [Related]

  • 6. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials.
    Dunner DL, Lipschitz A, Pitts CD, Davies JT.
    Clin Ther; 2005 Dec; 27(12):1901-11. PubMed ID: 16507376
    [Abstract] [Full Text] [Related]

  • 8. Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline.
    Lanza di Scalea T, Hanusa BH, Wisner KL.
    J Clin Psychiatry; 2009 Mar; 70(3):423-8. PubMed ID: 19284932
    [Abstract] [Full Text] [Related]

  • 9. Sexual function during bupropion or paroxetine treatment of major depressive disorder.
    Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S.
    Can J Psychiatry; 2006 Mar; 51(4):234-42. PubMed ID: 16629348
    [Abstract] [Full Text] [Related]

  • 10. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial.
    Misri S, Reebye P, Corral M, Milis L.
    J Clin Psychiatry; 2004 Sep; 65(9):1236-41. PubMed ID: 15367052
    [Abstract] [Full Text] [Related]

  • 11. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 12. Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.
    Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE.
    J Clin Psychiatry; 2006 May; 67(5):761-70. PubMed ID: 16841626
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.
    Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack WH, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP.
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):762-72. PubMed ID: 11437014
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of levomilnacipran sustained release 40 mg, 80 mg, or 120 mg in major depressive disorder: a phase 3, randomized, double-blind, placebo-controlled study.
    Asnis GM, Bose A, Gommoll CP, Chen C, Greenberg WM.
    J Clin Psychiatry; 2013 Mar; 74(3):242-8. PubMed ID: 23561229
    [Abstract] [Full Text] [Related]

  • 15. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ.
    Eur Psychiatry; 2006 Sep; 21(6):367-78. PubMed ID: 16697153
    [Abstract] [Full Text] [Related]

  • 16. A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder.
    Kasper S, Olivieri L, Di Loreto G, Dionisio P.
    Curr Med Res Opin; 2005 Aug; 21(8):1139-46. PubMed ID: 16083521
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
    Fava M, Thase ME, DeBattista C.
    J Clin Psychiatry; 2005 Jan; 66(1):85-93. PubMed ID: 15669893
    [Abstract] [Full Text] [Related]

  • 18. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
    Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M.
    J Clin Psychiatry; 2005 Aug; 66(8):1038-42. PubMed ID: 16086620
    [Abstract] [Full Text] [Related]

  • 19. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K, Perry CM.
    CNS Drugs; 2001 Aug; 15(8):643-69. PubMed ID: 11524036
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
    Schatzberg A, Roose S.
    Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.